In addition, since THIQ is able to elicit a partial response from some mutated MC4Rs, our findings suggest that THIQ may be a potential obesity therapeutic for people carrying MC4R mutations. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.